Can Yttrium 90 eradicate cancer?

When it comes to cancer, people often feel fearful, and liver cancer is particularly frightening due to its high mortality rate and rapid development. After most patients learn that they have liver cancer, their first reaction is to know how much longer they can live? How to choose the most suitable treatment method for oneself?

1：What are the challenges faced by cancer patients?

As is well known, surgery has always been the preferred treatment option for liver cancer patients. Early liver cancer patients can achieve long-term survival and even cure through liver resection, liver transplantation, and other procedures. However, surgical treatment is not suitable for all liver cancer patients and must meet prerequisite conditions before surgery can be performed, including good liver function, appropriate tumor location, tumor size, sufficient residual liver after resection, and the ability to maintain normal liver function. These harsh conditions make it almost impossible for some liver cancer patients, especially those in the middle and late stages, to undergo surgical treatment.

2：How to solve this dilemma?

Based on the above conditions, do cancer patients have no chance of undergoing surgery? Obviously not, downgrading conversion therapy can help liver cancer patients who cannot undergo surgical treatment regain the opportunity for surgery. Yttrium [90Y] microspheres selective internal radiation therapy (SIRT) is an effective treatment for liver cancer, and authoritative guidelines at home and abroad also recommend its use for the conversion therapy of unresectable liver cancer.
As of now, Yttrium 90 Microspheres therapy has been clinically applied in over 50 countries and regions worldwide for more than 20 years, treating over 150000 patients. Its safety and effectiveness have been widely verified. In China, yttrium [90Y] product was introduced and officially approved for market in 2022, and it has achieved significant results so far.

3：How to operate yttrium [90Y] microspheres?

Yttrium [90Y] microsphere selective internal radiation therapy is a local treatment method operated by interventional doctors. A microcatheter is used to place resin microspheres containing radioactive material yttrium [90Y] into the hepatic artery. The microspheres reach the liver tumor site with the blood flow and efficiently kill the tumor by releasing beta rays. Its radiation energy is high, the treatment is accurate, and it delivers precise strikes to the tumor from the inside out. This therapy is particularly suitable for liver cancer patients who cannot accept surgical treatment or other treatment methods with poor results, which can effectively improve their quality of life and prolong their survival.

4：What is the use effect of yttrium [90Y] microspheres?

Yttrium 90 can not only treat conventional tumor cells, but also be an effective method for treating metastatic liver tumors such as colorectal cancer liver metastasis and metastatic neuroendocrine tumors. Patients can choose Yttrium 90 treatment according to their own situation. All patients need to undergo strict screening before receiving Yttrium 90 treatment, and only those who pass the assessment can receive treatment, so the safety is very high. Therefore, whether it is early-stage patients, mid to late stage patients, or patients who are unwilling to undergo surgical resection, Yttrium 90 treatment can be considered to improve their condition and quality of life.
As for the survival rate of Yttrium 90 treatment, it depends on the specific pathological stage and condition of the patient.
Yttrium 90 therapy has a wide range of indications for liver malignancies, including but not limited to:
(1) For resectable populations with high recurrence risk, neoadjuvant therapy can be applied to reduce the risk of recurrence;
(2) Late stage patients can use Yttrium 90 for tumor reduction and enlargement of the remaining liver, in order to strive for curative surgery and the opportunity for liver transplantation;
(3) For patients who are unwilling to undergo surgical resection, radioactive liver segment ablation can also be performed to achieve the same effect as radical surgery.

Overall, Yttrium 90 therapy provides a new treatment option for liver cancer patients, especially for those who cannot undergo surgical treatment. It may help them prolong their survival and improve their quality of life. However, the survival rate of Yttrium 90 treatment for several years still needs to be evaluated based on the specific situation of the patient, and cannot be generalized. If the condition is not very serious for cancer patients, it is recommended to choose conservative treatment, which can be solved by using anti-cancer products to address their own difficulties. For example, 6-DIAZO-5-OXO-L-NORLEUCINE,Bevacizumab,Rituximab etc,. At the same time, when receiving treatment, patients should maintain a positive attitude, communicate fully with doctors, and jointly develop the most suitable treatment plan for themselves.

Disclaimer: The information published on this website comes from the internet, which does not mean that this website agrees with its views or confirms the authenticity of the content. Please pay attention to distinguish it. In addition, the products provided by our company are only used for scientific research. We are not responsible for the consequences of any improper use.

If you are interested in our products, or have critical suggestions on our articles or are not completely satisfied with the products received, Please also contact us via Email ：sales6@faithfulbio.com ; Our team is committed to ensuring the complete satisfaction of customers.